v3.25.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities    
Net loss $ (134,954) $ (156,902)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 37,308 35,947
Amortization of operating lease right-of-use assets and intangible assets 1,296 1,468
Non-cash interest expense 1,815 1,282
Stock-based compensation 1,198 658
Reserve on inventory 3,753 0
Loss (gain) on disposal of property and equipment 320 (71)
Loss on lease impairment 0 7,616
Gain from forgiveness of accounts payable and deposits, net 0 (518)
HSL s.l.r. settlement adjustment (295) 0
Gain on foreign exchange 0 287
Change in fair value of notes payable, warrant liabilities, and derivative call options (5,380) (20,640)
Change in fair value of related party notes payable and related party warrant liabilities 5,427 339
Other 168 0
Changes in operating assets and liabilities:    
Accounts receivables (645) 0
Deposits (2,331) 3,561
Inventory 630 5,484
Other current and non-current assets 1,566 9,620
Accounts payable (4,059) (1,908)
Financial obligations on lease back transaction 0 1,353
Operating lease liabilities (1,977) (2,081)
Net cash used in operating activities (43,608) (29,091)
Cash flows from investing activities    
Proceeds from the sale of equipment 0 87
Payments for property and equipment (5,007) (358)
Net cash used in investing activities (5,007) (271)
Cash flows from financing activities    
Proceeds from other financial obligations 4,384 0
Payments of notes payable issuance costs (1,521) (189)
Net cash provided by financing activities 55,052 26,715
Effect of exchange rate changes on cash and restricted cash (350) (1)
Net (decrease) increase in cash and restricted cash 6,087 (2,648)
Cash and restricted cash, beginning of period 7,174 4,025
Cash and restricted cash, end of period 13,261 1,377
Cash and restricted cash    
Cash 13,228 793
Restricted cash 33 584
Cash, cash equivalents, restricted cash, and restricted cash equivalents 13,261 1,377
Supplemental disclosure of cash flow information    
Cash paid for interest 2,818 465
Cash paid for taxes 0 0
Supplemental disclosure of noncash investing and financing activities    
Additions of property and equipment included in accounts payable and accrued expenses 43,893 42,690
Settlement of vendor liability in Class A Common Stock 2,245 0
Conversion of notes payable, related party notes payable and accrued interest into Class A Common Stock 35,572 17,240
Issuance of warrants with the SPA Portfolio Notes 32,328 10
SPA Note issuance costs included in accounts payable and accrued expenses 393 0
Recognition of right-of use assets and liabilities for new leases and lease modifications 6,229 0
Nonrelated Party    
Adjustments to reconcile net loss to net cash used in operating activities:    
Loss on settlement of notes payable 38,378 58,381
Changes in operating assets and liabilities:    
Accrued expenses and other current and non-current liabilities 11,241 7,624
Cash flows from financing activities    
Proceeds from notes payable, net of original issuance discount 48,570 23,916
Payments of notes payable and other financing obligations (367) (12)
Related Party    
Adjustments to reconcile net loss to net cash used in operating activities:    
Loss on settlement of notes payable 3,040 14,295
Changes in operating assets and liabilities:    
Accrued expenses and other current and non-current liabilities (11) 0
Accrued interest expense (96) 5,114
Cash flows from financing activities    
Proceeds from notes payable, net of original issuance discount 4,601 3,000
Payments of notes payable and other financing obligations $ (615) $ 0